Loading company…
PLD Technology develops cell-free protein expression products and services for researchers and biopharma companies.
Founded in 2017 in Suzhou, China, PLD Technology develops cell-free protein expression technology, kits and customized services for biopharmaceutical companies and research institutions. Its work includes peptides, recombinant proteins, antibodies, vaccines and large molecule protein drugs. The company has applied for 9 patents, 6 of which have been authorized, and counts Wuxi Biologics and Zhejiang University among its clients. It closed pre-Series A funding in June 2024 and received strategic investment from Tailong VC and Winfast Holding in September 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in